China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...
InxMed Co., Ltd, a clinical-stage biotechnology startup based in China, has announced that it had completed $5...
China's Adagene, a company transforming the discovery and development of antibody-based therapies, has announced a...
InnoCare Pharma, a leading biopharmaceutical company, has announced the Investigational New Drug (IND) approval of its B...
Shanghai Fosun Pharmaceutical (Group) Co. and Insilico Medicine have entered into a collaboration agreement to advance t...
Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, has announced that its Phase 2 COVID-19 trial...
South Korea-based startup Astrogen and Paris-based firm Iktos have announced a research collaboration to use A...
PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery ...
China-based BeiGene has announced an option, collaboration and license agreement with Novartis Pharma AG to develop, man...
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan’...
Experimental results have been published for the first time showing that an antiviral drug containing niclosamide, an an...
South Korea-based startup Standigm Inc. has announced the signing of a Memorandum of Understanding (MoU) with Institut P...
The limitations of the existing drug discovery paradigm reveals that there are still no effective prevention or real cur...
AUM Biosciences is a global clinical-stage biotech company, focused on discovering and developing novel target...
Pfizer Inc. has announced an agreement with the US government to supply 10 million treatment courses of its investi...
Pfizer Inc. has announced that it is seeking Emergency Use Authorization (EUA) of its investigational oral antivira...
South Korea-based GI Innovation has inked a biopharmaceutical manufacturing and development based Memorandum o...
Singapore's AUM Biosciences (AUM) has completed of $27 million series A funding round to develop a drug pipeline focused...
